(Q30419743)

16 August 2017

0 references

18-Fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: a case series (English)

1 reference

positron emission tomography

16 August 2017

1 reference

1 reference

Costi D Sifri

3

0 references

Eric R. Houpt

series ordinal

5

object named as

Eric R Houpt

1 reference

16 August 2017

1

Scott K Heysell

1 reference

16 August 2017

Tania A Thomas

2

1 reference

16 August 2017

Patrice K Rehm

series ordinal

4

1 reference

16 August 2017

21 March 2013

1 reference

16 August 2017

BMC Pulmonary Medicine

1 reference

16 August 2017

13

1 reference

16 August 2017

14

1 reference

Creative Commons Attribution 2.0 Generic

16 August 2017

start time

21 March 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637578

Is there a role for fluorine 18 fluorodeoxyglucose-positron emission tomography and positron emission tomography/computed tomography in evaluating patients with mycobacteriosis? A systematic review.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637578

Understanding latent tuberculosis: a moving target

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637578

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637578

The spectrum of latent tuberculosis: rethinking the biology and intervention strategies

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637578

Prediction of residual disease of spine infection using F-18 FDG PET/CT.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637578

Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637578

Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637578

Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study

20 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-13-14

Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-13-14

Patterns of pulmonary tuberculosis on FDG-PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-13-14

Double-phase 18F-FDG PET-CT for determination of pulmonary tuberculoma activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-13-14

FDG PET/CT for therapeutic response monitoring in multi-site non-respiratory tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-13-14

Use of 18F-FDG PET to predict response to first-line tuberculostatics in HIV-associated tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2466-13-14

Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637578

Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23514625

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Evaluation and management of solitary and multiple pulmonary nodules

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23514625

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

(18)F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23514625

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2466-13-14

1 reference

Dimensions Publication ID

16 August 2017

0 references

1 reference

16 August 2017

PubMed publication ID

23514625

1 reference